Page last updated: 2024-08-24

cremophor el and Experimental Mammary Neoplasms

cremophor el has been researched along with Experimental Mammary Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bathula, SR; Conwell, C; Huang, L; Liu, F; Liu, Y; Park, JY; Zhang, Y1
Bikram, M; Furgeson, DY; Janát-Amsbury, MM; Kern, S; Kim, SW; Lee, M; Yockman, JW1
Allémann, E; Benrezzak, O; Boyle, RW; Brasseur, N; Gurny, R; Kudrevich, SV; Leroux, JC; Rousseau, J; Van Lier, JE1
Allémann, E; Brasseur, N; Kudrevich, SV; Lewis, K; Rousseau, J; van Lier, JE1
Brasseur, N; Jones, MC; Leroux, JC; Taillefer, J; van Lier, JE1

Other Studies

5 other study(ies) available for cremophor el and Experimental Mammary Neoplasms

ArticleYear
Targeted cancer therapy with novel high drug-loading nanocrystals.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:8

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Female; Folate Receptors, GPI-Anchored; Glycerol; Hemolysis; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Neoplasms; Paclitaxel; Poloxamer; Receptors, Cell Surface; Surface-Active Agents

2010
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2004, Volume: 9, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Combined Modality Therapy; Female; Genetic Therapy; Glycerol; Interleukin-12; Lipids; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel; Plasmids; Polyethyleneimine

2004
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:5

    Topics: Animals; Colloids; Delayed-Action Preparations; Emulsions; Glycerol; Indoles; Injections, Intravenous; Lactates; Lactic Acid; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Photochemotherapy; Polyesters; Polyethylene Glycols; Polymers; Radiation-Sensitizing Agents; Solvents; Tissue Distribution

1995
Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
    International journal of cancer, 1996, Jun-11, Volume: 66, Issue:6

    Topics: Animals; Biodegradation, Environmental; Coloring Agents; Drug Carriers; Emulsions; Glycerol; Indoles; Lactates; Lactic Acid; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Microspheres; Neoplasm Transplantation; Organometallic Compounds; Particle Size; Photochemotherapy; Polyesters; Polyethylene Glycols; Polymers; Radiation-Sensitizing Agents; Solubility; Suspensions; Thigh; Tumor Cells, Cultured

1996
Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs.
    Journal of pharmaceutical sciences, 2000, Volume: 89, Issue:1

    Topics: Acrylamides; Animals; Antineoplastic Agents; Glycerol; Hydrogen-Ion Concentration; Indoles; Mammary Neoplasms, Experimental; Mice; Micelles; Organometallic Compounds; Particle Size; Photochemotherapy; Photosensitizing Agents; Polymethacrylic Acids; Solubility; Surface-Active Agents; Tumor Cells, Cultured; Water

2000